Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Abbott Labs hikes quarterly dividend by 10%
MarketWatch
Saturday, February 20, 2010 - 10:47am
tags:
Abbott Laboratories
Does India Want Drug Innovation or Not?
WSJ
Saturday, February 20, 2010 - 10:47am
tags:
India, innovation
Drug stocks slip; Shire climbs on earnings report
Marketwatch
Friday, February 19, 2010 - 10:53am
tags:
drug stocks, Shire
Healthcare a Focus for Big Moves by Icahn
Yahoo/Indie Research
Friday, February 19, 2010 - 10:51am
tags:
Carl Icahn, Biogen Idec, Amylin, Genzyme, Forest Labs, Exelixis
Sepracor merges and CEO Adams jumps to Inspire
Fierce Biotech
Friday, February 19, 2010 - 10:49am
tags:
Sepracor, Inspire
New York Bill On Gardasil Vaccination On Hold
Pharmalot
Friday, February 19, 2010 - 10:48am
tags:
New York, Gardasil, vaccines, HPV, Merck
Obama takes new tack on healthcare reform
Fierce Pharma
Friday, February 19, 2010 - 10:47am
tags:
Obama, healthcare reform
FDA Boasts About Approvals Of Cancer Drugs
Pharmalot
Friday, February 19, 2010 - 10:44am
tags:
FDA, cancer
ARYx cuts staff, explores future options
Bizjournals.com
Friday, February 19, 2010 - 10:29am
tags:
ARYx, layoffs
Glaxo cancer drugs given European greenlight
Yahoo/AP
Friday, February 19, 2010 - 10:28am
tags:
GSK, Europe, Tykerb, Votrient
CytRx Puts Its Cancer Pipeline to the Test
Seeking Alpha
Friday, February 19, 2010 - 9:26am
tags:
CytRx, cancer, pipelines
7 Reasons Curis Is Worth the Risk
Seeking Alpha
Friday, February 19, 2010 - 9:25am
tags:
Curis, Genentech, CompuGen, Cepheid
Novartis' Tasigna gets FDA priority review
Reuters
Friday, February 19, 2010 - 9:18am
tags:
Tasigna, FDA, Novartis, leukemia
United Therapeutics pulls Tyvaso application
Yahoo/AP
Friday, February 19, 2010 - 9:16am
tags:
United Therapeutics, Tyvaso, Europe
GlaxoSmithKline reviewing FDA labelling proposals
Marketwatch
Friday, February 19, 2010 - 9:14am
tags:
GSK, FDA, Advair, asthma
Shire Profit Rises on Higher Vyvanse Sales
Bloomberg
Friday, February 19, 2010 - 9:14am
tags:
Shire, earnings, Vyvanase
Drug Stocks That Deserve A Closer Look
Investopedia
Friday, February 19, 2010 - 9:12am
tags:
Pfizer, Merck, JNJ, Bristol-Myers Squibb
Roche’s Rituxan Gains U.S. Backing for New Cancer Use
Bloomberg
Thursday, February 18, 2010 - 8:49pm
tags:
Roche, Rituxan, leukemia
Jazz files NDA for fibromyalgia treatment
Bizjournals.com
Thursday, February 18, 2010 - 8:48pm
tags:
Jazz Pharmaceuticals, NDA, fibromyalgia
Asthma drugs get stiff new warnings
Forbes
Thursday, February 18, 2010 - 8:47pm
tags:
asthma, Advair, warnings, GSK

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.